Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check19 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are adopting “Super Intelligence” (SI) terminology in place of “Artificial Intelligence” (AI).SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check33 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check54 days agoChange DetectedThe history list now shows a new revision label v3.7.0, replacing the prior v3.6.6. This reflects a new version of the page's record history interface.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page history shows a release version update, replacing v3.6.5 with v3.6.6 in the footer/release notes.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.